The microRNA-9/B-lymphocyte-induced maturation protein-1/IL-2 axis is differentially regulated in progressive HIV infection

European Journal of Immunology

Volumn 43, Issue 2, 2013, Pages 510-520

  Seddiki, Nabila ^a,b,f,g   Phetsouphanh, Chansavath ^a,b   Swaminathan, Sanjay ^a,b   Xu, Yin ^a,b   Rao, Sudha ^c   Li, Jasmine ^c   Sutcliffe, Elissa L ^c   Denyer, Gareth ^d   Finlayson, Robert ^e   Gelgor, Linda ^a,b   Cooper, David A ^a,b   Zaunders, John ^a   Kelleher, Anthony D ^a,b  

^a St Vincent's Centre for Applied Medical Research   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c Biology and Environment   (Australia)

^d UNIVERSITY OF SYDNEY   (Australia)

^e Taylor Square Clinic ^*  (Australia)

^f FACULTÉ DE MÉDECINE   (France)

^g INSERM U955   (France)

Author keywords

Blimp 1; CD4+ T cells; HIV; IL 2; MiR 9

Indexed keywords

B LYMPHOCYTE INDUCED MATURATION PROTEIN 1; INTERLEUKIN 2; MICRORNA 155; MICRORNA 9; PROGRAMMED DEATH 1 RECEPTOR;

ADULT; ARTICLE; CD4 LYMPHOCYTE COUNT; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DOWN REGULATION; FEMALE; GENE LOCUS; GENE REPRESSION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; T LYMPHOCYTE ACTIVATION; UPREGULATION; VIRUS LOAD;

ADULT; B-LYMPHOCYTES; CD4-POSITIVE T-LYMPHOCYTES; CELL DIFFERENTIATION; CELL LINE, TUMOR; DOWN-REGULATION; FEMALE; HIV INFECTIONS; HUMANS; INTERLEUKIN-2; JURKAT CELLS; MALE; MICRORNAS; MIDDLE AGED; PROGRAMMED CELL DEATH 1 RECEPTOR; RECEPTORS, ANTIGEN, T-CELL; REPRESSOR PROTEINS; UP-REGULATION; YOUNG ADULT;

EID: 84873704081     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201242695     Document Type: Article

References (28)

1. Zaunders, J., Dyer, W., Munier, M., Ip, S., Liu, J., Amyes, E., Rawlinson, W. et al., CD127+CCR5+CD38+++ CD4+ Th1 effector cells are an early component of the primary immune response to vaccinia virus and precede development of interleukin-2+ memory CD4+ T cells. J. Virol. 2006. 80: 10151-10161.
2. Porichis, F. and Kaufmann, D. E., HIV-specific CD4 T cells and immune control of viral replication. Curr. Opin. HIV AIDS 2011. 6: 174-180.
3. McMichael, A. J., Borrow, P., Tomaras, G. D., Goonetilleke, N. and Haynes, B. F., The immune response during acute HIV-1 infection: clues for vaccine development. Nat. Rev. Immunol. 2010. 10: 11-23.
4. Day, C., Kaufmann, D., Kiepiela, P., Brown, J., Moodley, E., Reddy, S., Mackey, E. et al., PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression. Nature 2006. 443: 350-354.
5. Petrovas, C., Casazza, J., Brenchley, J., Price, D., Gostick, E., Adams, W., Precopio, M. et al., PD-1 is a regulator of virus-specific CD8+ T cell survival in HIV infection. J. Exp. Med. 2006. 203: 2281-2292.
6. Trautmann, L., Janbazian, L., Chomont, N., Said, E., Gimmig, S., Bessette, B., Boulassel, M. et al., Upregulation of PD-1 expression on HIV-specific CD8+ T cells leads to reversible immune dysfunction. Nat. Med. 2006. 12: 1198-1202.
7. Martins, G. and Calame, K., Regulation and functions of Blimp-1 in T and B lymphocytes. Annu. Rev. Immunol. 2008. 26: 133-169.
8. Rutishauser, R., Martins, G., Kalachikov, S., Chandele, A., Parish, I., Meffre, E., Jacob, J. et al., Transcriptional repressor Blimp-1 promotes CD8(+) T cell terminal differentiation and represses the acquisition of central memory T cell properties. Immunity 2009. 31: 296-308.
9. Kallies, A., Xin, A., Belz, G. and Nutt, S., Blimp-1 transcription factor is required for the differentiation of effector CD8(+) T cells and memory responses. Immunity 2009. 31: 283-295.
10. Shin, H., Blackburn, S., Intlekofer, A., Kao, C., Angelosanto, J., Reiner, S. and Wherry, E., A role for the transcriptional repressor Blimp-1 in CD8(+) T cell exhaustion during chronic viral infection. Immunity 2009. 31: 309-320.
11. Nie, K., Gomez, M., Landgraf, P., Garcia, J., Liu, Y., Tan, L., Chadburn, A. et al., MicroRNA-mediated down-regulation of PRDM1/Blimp-1 in Hodgkin/Reed-Sternberg cells: a potential pathogenetic lesion in Hodgkin lymphomas. Am. J. Pathol. 2008. 173: 242-252.
12. Gong, D. and Malek, T., Cytokine-dependent Blimp-1 expression in activated T cells inhibits IL-2 production. J. Immunol. 2007. 178: 242-252.
13. Martins, G., Cimmino, L., Liao, J., Magnusdottir, E. and Calame, K., Blimp-1 directly represses Il2 and the Il2 activator Fos, attenuating T cell proliferation and survival. J. Exp. Med. 2008. 205: 1959-1965.
14. Sutcliffe, E. L., Bunting, K. L., He, Y. Q., Li, J., Phetsouphanh, C., Seddiki, N., Zafar, A. et al., Chromatin-associated protein kinase C-theta regulates an inducible gene expression program and microRNAs in human T lymphocytes. Mol. Cell. 2011. 41: 704-719.
15. Lodish, H., Zhou, B., Liu, G. and Chen, C., Micromanagement of the immune system by microRNAs. Nat. Rev. Immunol. 2008. 8: 120-130.
16. Bazzoni, F., Rossato, M., Fabbri, M., Gaudiosi, D., Mirolo, M., Mori, L., Tamassia, N. et al., Induction and regulatory function of miR-9 in human monocytes and neutrophils exposed to proinflammatory signals. Proc. Natl. Acad. Sci. USA 2009. 106: 5282-5287.
17. Thiele, S., Wittmann, J., Jack, H. M. and Pahl, A., miR-9 enhances IL-2 production in activated human CD4(+) T cells by repressing Blimp-1. Eur. J. Immunol. 2012. 42: 2100-2108.
18. Bignami, F., Pilotti, E., Bertoncelli, L., Ronzi, P., Gulli, M., Marmiroli, N., Magnani, G. et al., Stable changes in CD4+ T-lymphocyte microRNA expression following exposure to HIV-1. Blood 2012. 119: 6259-6267.
19. Rossi, R. L., Rossetti, G., Wenandy, L., Curti, S., Ripamonti, A., Bonnal, R. J., Birolo, R. S. et al., Distinct microRNA signatures in human lymphocyte subsets and enforcement of the naive state in CD4+ T cells by the microRNA miR-125b. Nat. Immunol. 2011. 12: 796-803.
20. + T-cells from HIV-1-infected individuals. PLoS Pathog. 2010. 6: e1000781.
21. Harari, A., Vallelian, F., Meylan, P. R. and Pantaleo, G., Functional heterogeneity of memory CD4 T cell responses in different conditions of antigen exposure and persistence. J. Immunol. 2005. 174: 1037-1045.
22. Abrams, D., Levy, Y., Losso, M., Babiker, A., Collins, G., Cooper, D., Darbyshire, J. et al., Interleukin-2 therapy in patients with HIV infection. N. Engl. J. Med. 2009. 361: 1548-1559.
23. Sereti, I., Imamichi, H., Natarajan, V., Imamichi, T., Ramchandani, M., Badralmaa, Y., Berg, S. et al., In vivo expansion of CD4CD45RO-CD25 T cells expressing foxP3 in IL-2-treated HIV-infected patients. J. Clin. Invest. 2005. 115: 1839-1847.
24. Cretney, E., Xin, A., Shi, W., Minnich, M., Masson, F., Miasari, M., Belz, G. T. et al., The transcription factors Blimp-1 and IRF4 jointly control the differentiation and function of effector regulatory T cells. Nat. Immunol. 2011. 12: 304-311.
25. Stewart, G. J., Ashton, L. J., Biti, R. A., Ffrench, R. A., Bennetts, B. H., Newcombe, N. R., Benson, E. M. et al., Increased frequency of CCR-5 delta 32 heterozygotes among long-term non-progressors with HIV-1 infection. The Australian long-term non-progressor study group. AIDS 1997. 11: 1833-1838.
26. + regulatory T cells in adult life. Blood 2006. 107: 2830-2838.
27. Sutcliffe, E. L., Parish, I. A., He, Y. Q., Juelich, T., Tierney, M. L., Rangasamy, D., Milburn, P. J. et al., Dynamic histone variant exchange accompanies gene induction in T cells. Mol. Cell. Biol. 2009. 29: 1972-1986.
28. Pokholok, D. K., Zeitlinger, J., Hannett, N. M., Reynolds, D. B. and Young, R. A., Activated signal transduction kinases frequently occupy target genes. Science 2006. 313: 533-536.